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Abstract
Objective—Data from animal models show that in utero exposure to a maternal high fat diet 
(HFD) renders susceptibility of these offspring to the adult onset of metabolic syndrome. We and 
others have previously shown that epigenetic modifications to histones may serve as a molecular 
memory of the in utero exposure, rendering risk of adult disease. Because mice heterozygous for 
GLUT4 (insulin sensitive glucose transporter) born to wild-type (WT) mothers demonstrate 
exacterbated metabolic syndrome when exposed to a high fat diet in utero, we sought to analyze 
the genome-wide epigenetic changes which occur in the fetal liver in susceptible offspring.
Study Design—WT and Glut4+/− (G4+/−) offspring of WT mothers exposed either to a control 
or a HF diet in utero were studied. Immunoblotting was used to measure hepatic histone 
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modifications of fetal and 5 week animals. Chromatin immunoprecipitation (ChIP) followed by 
hybridization to chip arrays (ChIP on chip) was utilized to detect genome-wide changes of histone 
modifications with HFD exposure.
Results—We found that levels of hepatic H3K14ac and H3K9me3 significantly increased with 
HFD exposure in WT and G4+/− fetal and 5 week offspring. Pathway analysis of our ChIP on chip 
data reveal differential H3K14ac and H3K9me3 enrichment along pathways which regulate lipid 
metabolism, specifically in the promoter regions of Pparg, Ppara, Rxra and Rora.
Conclusion—We conclude that HFD exposure in utero is associated with functional alterations 
to fetal hepatic histone modifications in both WT and G4+/− offspring, some which persist up to 5 
weeks of age.
Keywords
developmental origins of adult disease; GLUT4; H3K14ac; H3K9me3
INTRODUCTION
According to the developmental origins of health and disease (DOHaD) hypothesis, the in 
utero experience can have a profound effect on the individual. Studies have suggested that 
the effects of a suboptimal intrauterine milieu can persist into adulthood1. In utero exposure 
to either a maternal low protein diet, caloric restriction or a maternal high fat diet (HFD), is 
associated with an increased susceptibility to the adult onset of metabolic syndrome2, 3. In 
the current era of obesity, studies concerning how a mother’s HFD may influence the health 
of her offspring are of increasing relevance. High fat diet consumption during pregnancy is 
associated with gestational diabetes mellitus 4. Animal models of in utero HFD exposure 
have shown that offspring are more susceptible to fatty liver in early life as well as increased 
adiposity, diabetes and cardiovascular disease in adulthood 3, 5–8. The question therefore 
remains, how can the memory of an exposure only experienced during gestation be 
maintained over the lifetime of the individual?
The possibility that epigenetic modifications contribute to this memory is an intriguing one. 
Epigenetic modifications constitute changes to the local chromatin structure that do not 
change the underlying DNA sequence. The addition or removal of post-translational histone 
modifications alongside changes in DNA methylation patterns are potential mechanisms that 
could contribute to the memory of an in utero exposure. Some histone modifications are 
enriched within the promoters of transcriptionally active genes, such as acetylation of lysine 
14 of histone H3 (H3K14ac)9, 10 while other modifications such as trimethylation of lysine 9 
of histone H3 (H3K9me3) are enriched in promoters of repressed genes as well as within 
heterochromatin 11–13. It is also well established that activating and repressive marks are not 
mutually exclusive, even within the same promoter. During embryogenesis, chromatin 
domains which contain both repressive and activating motifs cluster throughout the 
genome 14. Our previous work in a non-human primate model has demonstrated that HFD 
exposure in utero alters the fetal hepatic histone code 15. Specifically, hepatic H3K14ac is 
increased in the HFD exposed fetal animals 15, 16. H3K14 appears particularly sensitive to 
the intrauterine milleu as it is also modified in a rat model of nutrient restriction in skeletal 
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muscle 17. How these modifications are established and their relationship to the 
susceptibility to the adult onset of disease remains to be fully investigated.
Not every animal exposed to a HFD is equally susceptible, begging the question as to 
whether the offspring genotype may serve as a modifier of the in utero environment. We 
have studied offspring heterozygous for the Glut4 gene (G4+/−) from WT mothers fed a 
HFD 18. GLUT4 haploinsufficiency results in peripheral insulin resistance, altered lipid 
metabolism and type 2 diabetes 19–22. It has been shown that exposure to a HFD during 
critical periods of development leads to development of metabolic syndrome such as 
increased adiposity, impaired glucose tolerance, and insulin insensitivity in G4+/− and WT 
offspring. Interestingly, genotype-dependent differences were observed, suggesting that 
haploinsufficiency of GLUT4 may result in a different metabolic remodeling in response to 
the HFD 18. Thus, it is possible that an interaction between the in utero environment 
(exposure to a maternal HFD) and the offspring genotype (specifically a heterozygous 
deletion of GLUT4) may lead to different epigenetic changes either protecting against or 
increasing the risk of developing metabolic disease.
Based on our findings of an altered hepatic epigenome in a non-human primate model of 
maternal HFD consumption 15, 16, 23, we sought to determine whether (1) an increase in 
hepatic acetylation is similarly observed in a murine model of maternal HFD exposure and 
(2) whether offspring genetically susceptible to metabolic syndrome (the G4+/− offspring) 18 
have a similarly altered hepatic epigenome with HFD exposure in order to study whether 
diet x genotype interactions may also contribute to offspring disease susceptibility. Because 
the paternal germline is the source of the Glut4 haploinsufficiency (and Glut4 is not 
expressed in the liver until late postnatal life 24), any intrauterine genotypic contribution 
would be attributable only to altered placental glucose and/or nutrient uptake in G4+/− 
offspring.
In this study we found that fetal hepatic H3K14ac and H3K9me3 increases with maternal 
HFD exposure. These alterations were also observed in animals at 5 weeks of age. 
Chromatin immunoprecipitation (ChIP) followed by hybridization to a promoter array chip 
(ChIP-on-chip) was used to determine which promoters on a genome-wide scale show 
differential enrichment for H3K14ac and H3K9me3 in response to maternal diet. We 
observed that these modifications are predominantly enriched among those gene promoters 
which relegate to lipid metabolism networks. We conclude that HFD exposure in fetal life is 
associated with significant alterations of distinct histone modifications, rendering enriched 
occupancy in the promoters of genes which regulate lipid metabolism.
MATERIALS AND METHODS
Murine model
All animal procedures were done in accordance with approved IRB protocols from both 
Baylor College of Medicine and Albert Einstein College of Medicine as previously 
described 8, 18. WT CD1 female mice were maintained on a control breeding chow 
(PicoLab® Mouse Diet #5058; 9% fat, 20% protein, 53% carbohydrate) or high fat (HF Bio-
Serv Product #F3282; 35.5% fat as lard, 20% protein, 36.3% carbohydrate) diet two weeks 
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prior to mating with G4+/− males throughout gestation and lactation. Offspring were weaned 
onto a low fat diet (Pico Lab #5053; 4.5% fat, 20% protein, 54.8% carbohydrate) at 
postnatal day 21. The animals used in this study were male WT and G4+/− offspring. For 
fetal tissue, pregnant mice were sacrificed at embryonic (e) day e18.5. Fetuses were 
sacrificed by decapitation and organs were immediately harvested and snap frozen using 
liquid nitrogen18.
Experimental methods can be found in the supplemental information.
RESULTS
Hepatic H3K14 acetylation and H3K9 trimethylation increase with HFD exposure in utero 
and during lactation
Immunoblotting was used to determine if hepatic histone modifications are altered in either 
WT or G4+/− offspring with HFD exposure (Figure 1A). In fetal liver at e18.5, H3K14ac is 
increased in both the WT (3.6-fold, p=0.002) and G4+/− (3.0-fold, p=0.002) offspring with 
HFD exposure (Figure 1B). H3K9me3 is also increased with HFD exposure in both the WT 
(5.7-fold, p=0.007) and G4+/− (4.6-fold, p=0.047) fetal offspring (Figure 1C).
Immunobloting was similarly performed on livers from 5 week old animals exposed in utero 
to a maternal control or HF diet and weaned onto a low fat diet two weeks before harvesting 
the tissue. In these animals, both H3K14ac and H3K9me3 are significantly increased in 
HFD exposed animals compared with control diet in both WT and G4+/− offspring (Figures 
1D and 1E). Relative levels of fetal hepatic H3K27me3, H4K20me3, H3K9ac, H3K18ac 
and H3K4me3 were found to be unchanged with HFD exposure in the fetal WT animals so 
were not further assessed (Supplementary Table 1).
Hepatic gene expression of histone modifying enzymes is reduced in WT 5 week old 
offspring with HFD exposure during lactation
Because of the observed increase in histone acetylation in the fetal and 5 week old animals, 
we hypothesized that expression levels of histone acetyltransferases would be altered. GCN5 
is a histone acetyltransferase of histone H3 25, 26. HDAC1, HDAC3 and SIRT1 deacetylate 
histone H3K14 27–30. Hepatic mRNA levels of these genes were measured in both fetal and 
5 week old animals in the WT and G4+/− offspring. While we failed to observe a significant 
alteration in expression in the fetal animals (Figure 2A), at 5 weeks of age, Sirt1 expression 
was significantly decreased when compared to the control diet exposed cohort in both WT 
and G4+/− animals (Figure 2B). In WT offspring, gene expression of Gcn5, Hdac1 and 
Hdac3 were also significantly reduced in 5 week old offspring who experience both prenatal 
and postnatal HFD exposure (Figure 2B).
ChIP on chip reveals that global H3K14ac and H3K9me3 are both enriched at the 
transcription start site (TSS) regardless of genotype or diet exposure in the fetal liver
In order to determine in the localization of H3K14ac and H3K9me3, ChIP-on-chip was 
performed on the fetal liver from WT and G4+/− offspring exposed to either control or HFD 
in utero (Figure 3A). Enrichment (as measured by log 2 IP/ Input) of these modifications 
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was plotted throughout the array as a means of internal validation 31, 32. Consistent with 
previous epigenome-wide characterizations 26, 33, we observed robust enrichment in a broad 
region surrounding the TSS in each of the eight groups studied (Figures 3B–C).
H3K14ac and H3K9me3 are differentially enriched in genes involved in lipid metabolism in 
the fetal liver
In order to determine promoter specific changes of H3K14ac and H3K9me3 in the fetal 
animals, gene lists were generated from the ChIP-on-chip data which demonstrated 
differential enrichment over input (Supplementary Tables 2–9). We then determined which 
genes had differential enrichment between the control and HFD groups (Supplementary 
Tables 10–13). Of interest were the genes significantly altered for both H3K14ac and 
H3K9me3: , 454 genes in the WT animals and 755 genes in the G4+/− aimals (Figure 3D). 
To determine if there is an offspring genotype effect on histone modification localization, 
the generated gene lists were analyzed for overlap for each modification between WT and 
G4+/− offspring (Figure 3E). When comparing genes differentially enriched between control 
and HFD for H3K14ac, 8% (427 out of 5182 total) of genes were similarly enriched 
between WT and G4+/− liver while 10% (566 out of 5588 total) of the genes enriched for 
H3K9me3 were found in both WT and G4+/− liver.
For the genomic regions enriched for H3K14ac or H3K9me3 between control and HFD 
exposed animals (Supplementary Tables 10–13), HOMER 34 was used to determine which 
transcription factor binding sites were significantly (Benjamini q-value < 0.05) represented 
in the dataset. In the WT animals, there were no known motifs enriched in either the 
H3K14ac or H3K9me3 datasets. However, analysis of the G4+/− offspring revealed 9 
significantly enriched motifs (Table 1). H3K14ac is differentially enriched in regions 
containing Gata1, 2, 4 and Myf5 binding motifs. H3K9me3 is differentially enriched in 
regions containing GFY, E2F, E2F4 and RUNX-AML binding motifs.
Genes important for lipid metabolism are differentially enriched in H3K14ac and H3K9me3 
in fetal livers of WT and G4+/− offspring
The generated gene lists were analyzed using Ingenuity Pathway Analysis (IPA) to 
determine which biological networks are differentially represented. For each group, lipid 
metabolism was the top network identified (Supplementary Table 14). In each analysis, four 
genes involved in lipid metabolism consistently emerged as central convergence nodes for 
the differentially represented pathways: Pparg, Ppara, Rora, and Rxra. Enrichment of 
H4K14ac and H3K9me3 within gene-specific promoters was interrogated employing qPCR 
on ChIP’ed DNA using primers proximal to the TSS (Supplementary Table 15). Indeed, 
both H3K14ac and H3K9me3 were enriched among both WT and G4+/− fetal liver 
following in utero HFD exposure compared to control diet (Figure 4 A–D).
We hypothesized that if there were an enrichment of these modifications with HFD 
exposure, this enrichment should correlate with significant alterations in gene-specific 
transcription. Pparg, Ppara, Rora and Rxra expression was quantified by qPCR (Figure 4 E
+F). Pparg was increased in the G4+/− HFD exposed fetuses compared with the control diet 
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group. Expression levels of Ppara, Rora and Rxra were not altered in HFD exposed fetuses 
in either the WT or G4+/− groups.
Promoter enrichment of H3K14ac and H3K9me3 is reversed at 5 weeks of age despite HFD 
exposure during lactation
We performed qPCR on H3K14ac and H3K9me3 ChIP’ed DNA using primers proximal to 
the TSS. At 5 weeks of age, both modifications are enriched with maternal HFD exposure in 
the Pparg promoter , but only among G4+/− offspring (Figure 5A). In HFD WT animals, 
there was a significant decrease in H3K14ac in the Ppara promoter (Figure 5B). Similarly, 
both H3K14ac and H3K9me3 were decreased in the Rora promoter with HFD exposure 
(Figure 5C). There were no significant changes in the Rxra promoter (Figure 5D). However, 
mRNA expression analysis demonstrated that Ppara expression was significantly decreased 
following maternal HFD exposure in both the WT and G4+/− 5 week old offspring (Figure 5 
E+F), while mRNA expression of Pparg and Rxra were significantly decreased only in the 
G4+/− offspring (Figure 5F).
COMMENT
In this study we undertook a discovery based, epigenome-wide approach to identifying 
which modifications were altered in the HFD exposed male offspring in fetal and postnatal 
life. Similar to our prior findings in a non-human primate model 15, 16, hepatic H3K14ac is 
increased in fetal life in the mouse. Hepatic H3K9me3 is also increased with HFD exposure 
in the fetal mouse, which was not observed in the non-human primate model. We conclude 
that K14ac and K9me3 are both modifiable in utero in response to maternal diet.
If epigenetic modifications contribute to a molecular memory of an in utero exposure, one 
would expect that changes which occur in utero would persist postnatally. Hepatic levels of 
both H3K14ac and K9me3 were measured in 5 week old offspring. Both the 5 week old WT 
and G4+/− offspring which were exposed to a HFD in utero showed an increase in both 
modifications compared with animals on a control diet. From this we conclude that in mice, 
an in utero exposure is sufficient to contribute to a change in the hepatic epigenome at 5 
weeks of age.
Consistent with our work in primates, the Sirt1 deacetylase showed a significant decrease in 
expression in the 5 week old WT and G4+/− offspring following HFD exposure. Not only 
does Sirt1 have many reported functions in lipid metabolism and obesity 35, due to its 
dependence on NAD+, its activity is directly related to cellular energy levels. We have 
shown that Sirt1 functions as a histone deacetylase with preference for H3K14ac in vitro 16. 
Based on our collective findings, we speculate that hepatic Sirt1 is a crucial epigenomic 
modulator of fetal and juvenile histone acetylation.
Using ChIP on chip with a genome-wide promoter array we observed that H3K14ac and 
H3K9me3 are uniquely enriched within a 4 kb region surrounding the TSS and peaking 
directly at the start site (Figures 3 B+C). Although this was not surprising, this observation 
is crucial to our concluding that the increase in H3K14ac and K9me3 abundance by 
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immunoblotting is not manifested through a delocalized spreading throughout the promoter 
regions.
We wanted to determine if both H3K14ac and H3K9me3 were potentially “marking” the 
same genes for reprogramming with HFD exposure. Such genes are potentially interesting 
because the mechanism(s) responsible for differential enrichment of each modification 
similarly targets these genes. Also, genes enriched for both repressive and permissive 
modifications in utero may be poised for rapid transcriptional activation when challenged ex 
utero 14. These histone marks may be key to understanding the susceptibility of offspring 
exposed to a maternal HFD to metabolic syndrome.
A surprising finding of this study was the difference in hepatic histone modification 
localization between the HFD exposed WT and G4+/− offspring. As evidenced in Figure 3E, 
only 10% of the genes which are differentially marked by either K14ac or K9me3 are 
similar between the WT and G4+/− animals. This was unexpected as Glut4 is not 
prominently expressed in fetal liver 24, and therefore it seemed unlikely that G4+/− offspring 
would have a different hepatic epigenome-wide pattern compared with WT offspring. 
However, it is important to note that Glut4 is expressed in mouse placenta 36 and therefore 
G4+/− offspring likely had a different intrauterine milieu resulting from a haploinsufficiency 
of the GLUT4 transporter in the placenta with altered placental nutrient uptake. It is also 
interesting to note the nearly two-fold increase in genes differentially enriched for H3K14ac 
in the G4+/− fetal liver when compared with the WT offspring (Figure 3D, 2912 genes vs 
1488 genes). This may suggest that a diet x genotype interaction contributes to the observed 
phenotypic outcomes of offspring exposed to a maternal HFD. Consistent with this finding, 
we also determined that 9 transcription factor binding motifs are enriched within the G4+/− 
offspring dataset, but not that of the WT.
The promoter occupancy of four genes (Ppara, Pparg, Rora and Rxra) revealed differential 
enrichment of both modifications between control and HFD animals in both the WT and 
G4+/− groups. We hypothesize that these modifications may act as markers of in utero and 
lactation exposure, marking the genes for future transcription with continued metabolic 
stress of HFD consumption. However, we did not observe a similar pattern in the 5 week old 
animals. While we cannot conclude that the marks set in fetal life remain unaltered 
postnatally, it is important to note that the 5 week old animals were all weaned onto a low 
fat chow which they consumed for two weeks prior to sacrifice. We hypothesize that 
because both hepatic H3K14ac and H3K9me3 are both responsive to changes in the diet, the 
exposure to low fat chow may allow for a subtle altered enrichment of the modifications.
We conclude that the fetal hepatic epigenome is modified following maternal HFD exposure 
in utero and during lactation to enrich specific histone modifications in the promoters of 
genes well-characterized as key regulators of lipid overload. Whether these modifications 
contribute to the increased susceptibility of metabolic syndrome in adulthood remains to be 
determined, but this robust characterization of the fetal and postnatal epigenomic landscape 
lends crucial impetus to such studies.
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MATERIALS AND METHODS
Immunoblotting
Immunoblots were performed as previously described 1. Briefly, acid extracted histones or 
whole cell lysates were run on 18% SDS-PAGE and transferred to polvinylidene fluoride 
(PVDF). Blots were incubated overnight at 4°C in primary antibody, washed three times and 
incubated for 45 minutes at room temperature in secondary antibody. Blots were visualized 
using Chemiluminescence. Bands were quantified using the UltraQuant system, and 
normalized to unmodified histone H3. The H3K9me3 antibody was purchased from 
Millipore (07–442); the H3K14ac antibody from Millipore (07–353) and total H3 from Cell 
Signaling (9715L). The HDAC1 and 3 antibodies were from Abcam (HDAC1 #46985; 
HDAC3 #28170). For the fetal animals an n of 5 per group was utilized and for the 5 week 
old animals, an n of 4 per group.
qPCR
RNA was extracted from liver using the Machery Nagel kit (740955.250) and converted to 
cDNA using Superscript III from Illumina (#18080-044). Commercially available TaqMan 
primers and probes were used for qPCR. Analysis was performed using the DDCT 
method 2. For the fetal animals an n of 5 per group was utilized, for the 5 week old animals 
there was an n of 4 per group.
ChIP
Chromatin immunoprecipitation was performed as previously described 3. Three fetal 
animals/ group were utilized. Histone modification antibodies were the same as from the 
western blots. Before the addition of antibody, 10% of the reaction was set aside as the 
input. Before genome wide amplification, samples were tested by qPCR for proper fold 
enrichment using previously published primers 4. Samples were amplified to approximately 
7.5µg using the Sigma WGA kit (WGA-2) and submitted to the Baylor Microarray Core 
Facility for processing.
Array hybridization
Fragmentation of 7.5µg of double-stranded DNA was completed with the aid of 0.2U of 
DNase I, Amplification Grade, from Life Technologies (18068-015), producing fragment 
products 50–200bp in length. Fragment sizes were verified on the Agilent Bioanalyzer. 
Fragmentation was followed by terminal labeling with terminal deoxynucleotidyl transferase 
and the Affymetrix® proprietary DNA Labeling Reagent that is covalently linked to biotin. 
Hybridization cocktails containing Affymetrix spike-in controls and fragmented, labeled 
double-stranded DNA were loaded onto Affymetrix GeneChip® Mouse Promoter 1.0R 
arrays. The arrays were hybridized for 16 hours at 45°C with rotation at 60 rpm in the 
Affymetrix GeneChip® Hybridization Oven 640. The arrays were washed and stained with a 
streptavidin, R-phycoerythrin conjugate stain using the Affymetrix GeneChip® Fluidics 
Station 450. Signal amplification was done using biotinylated antistreptavidin. The stained 
arrays were scanned on the Affymetrix GeneChip® Scanner 3000. The images were 
analyzed and quality control metrics recorded using Affymetrix Command Console.
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Array analysis
The analysis of ChIP-chip data was performed using Partek®, Genomic Suite™, Partek Inc. 
The CEL Files were imported and normalized by default method predefined in Partek, 
which includes Robust Multiarray Average (RMA) background correction, quantile 
normalization and Log 2 transformation. The difference of each comparison group was 
found by performing ANOVA, and then the MAT (Model based analysis of tiling-array) 
algorithm 5 was used to detect regions with enriched peaks. The p-value of the region is the 
empirical p-value of the most significant MAT score included within this region. MAT score 
of the region is the maximum MAT score for this region. The threshold for MAT score is 
3.0. Enriched region with overlapping genes were annotated with Mus musculus NCBI Build 
36.
Genes overlapping with significantly enriched regions were used to estimate the occupancy 
around TSS region. The probes corresponding to each region were identified and mapped 
into a window around transcription starting site (TSS) based on correct strand orientation. 
For each probe, the fold enrichment between the immunoprecipitated (IP) sample and 
negative control was calculated; the mean enrichment is the average of all the probes.
Transcription factor binding site motif analysis
Genomic regions identified by ChIP-chip as enriched for either H3K14ac or H3K9me3 in 
comparisons between control and HFD exposed animals were analyzed for transcription 
factor binding site motif enrichment using the findMotifsGenome.pl tool within the 
Hypergeometric Optimization of Motif EnRichment (HOMER) tool suite 6.
Statistical analysis
Statistical significance for immunoblotting and qPCR was calculated using a 2-tailed t-test 
in Excel with significance being a p-value of less than 0.05. The Known Motif Enrichment 
Results at a Benjamini multiple testing correction q-value < 0.05 were identified as being 
significantly enriched.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. H3K14ac and H3K9me3 are increased in the livers of HFD exposed WT and G4+/− 
offspring
(A) WT mothers were exposed to either a control or HFD during pregnancy and lactation. 
Epigenetic changes in both WT and G4+/− offspring were characterized. (B) Immunoblotting 
with antibodies specific for each histone modification reveal that H3K14ac is significantly 
increased in the fetal liver in the WT and G4+/− offspring. (C) Similar results are seen for 
H3K9me3 in the fetal animals. (D,E) The increase in each modifiaction persists in the livers 
of 5 week old animals in both WT and G4+/− offspring. All results were normalized to total 
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histone H3. Results are displayed as fold change compared with control diet exposed 
animals. P-values < 0.05 are designated *, and < 0.005 as **.
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Figure 2. Hepatic SIRT1 levels are reduced in 5 week old animals exposed in utero to a maternal 
HFD
(A) Using qRT-PCR levels of the histone acetyltransferase Gcn5 as well as the histone 
deacetylases Hdac1, Hdac3 and Sirt1 were analyzed. No significant changes with HFD 
exposure in WT and G4+/− animals were found. (B) Gcn5, Hdac1 and Hdac3 are all 
significantly decreased in the WT but not in the G4+/− animals. Sirt1 was significantly 
decreased with HFD exposure in both groups. P-values < 0.05 are designated *, and < 0.005 
as **.
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Figure 3. Chip on chip reveals a distinct profile for H3K14ac and H3K9me3 localization
(A) This schemata shows an overview of the samples processed by ChIP for ChIP on chip 
analysis. Livers from fetal WT or G4+/− animals exposed to either a control or a HFD in 
utero were used for ChIP using either H3K14ac or H3K9me3 antibodies. Localization of 
both H3K14ac and H3K9me3 in WT (B) or G4+/− (C) animals surrounding the TSS is 
calculated using Log 2 IP/IN. (D) Partek was used to generate lists of genes with differential 
promoter occupancy between control and HFD exposed animals. In the WT animals, 
H3K14ac was differentially enriched in the promoters of 1942 genes with HFD exposure, 
and H3K9me3 n 2781 genes. There were 454 genes common to each group. In G4+/− 
animals, H3K14ac was differentially enriched in the promoters of 3667 genes, and 
H3K9me3 in 3373 genes. There were 755 genes common to each group. (E) To compare the 
overlap in genes marked by each modification in WT and G4+/−offspring a Venn Diagram 
was created. In the WT offspring, 1942 are differentially enriched with HFD exposure, in 
the G4+/− offspring 3667 genes show differential enrichment. Less than 10% (427 genes) are 
shared between the two groups. For H3K9me3, the WT offspring have 2781 and the G4+/− 
offspring have 3373 genes differentially enriched by virtue of HFD exposure. Only 566 
genes are similar between the WT and G4+/− offspring.
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Figure 4. Both H3K14ac and H3K9me3 are enriched at site specific promoters with HFD 
exposure in the fetal liver
ChIP followed by site specific qPCR was used to determine enrichment (as calculated by 
percent input) of either H3K14ac or H3K9me3 within the promoters of (A) Pparg, (B) 
Ppara (C) Rora or (D) Rxra for WT and G4+/− offspring. qRT-PCR was used to determine 
if expression of each gene was altered in either the (E) WT or (F) G4+/−offspring. P-values < 
0.05 are designated *, and < 0.005 as **.
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Figure 5. Enrichment of H3K14ac and H3K9me3 at site specific promoters in the livers of 5 
week old animals
ChIP followed by site specific qPCR was used to determine enrichment (as calculated by 
percent input) of either H3K14ac or H3K9me3 within the promoters of (A) Pparg, (B) 
Ppara (C) Rora or (D) Rxra for WT and G4+/− offspring. qPCR was used to determine if 
expression of each gene was altered in either the (E) WT or (F) G4+/− offspring. P-values < 
0.05 are designated *, and < 0.005 as **.
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Table 1
Known motifs differentially enriched by virtue of maternal high fat diet exposure
Modification Motif Name q-value
H3K14ac Gata1 0.0095
H3K14ac Gata4 0.0436
H3K14ac Gata2 0.0436
H3K14ac Myf5 0.0436
H3K9me3 E2F 0.014
H3K9me3 GFY-Staf 0.014
H3K9me3 E2F4 0.0434
H3K9me3 GFY 0.0434
H3K9me3 RUNX-AML 0.0434
HOMER was used to determine known motifs enriched within the H3K14ac and H3K9me3 datasets.
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